Roger S. Day, ScD

Bryant J, Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics. 1995 Dec; 51 (4):1372-83. PMID: 8589229.

Day, RS. Treatment sequencing, asymmetry, and uncertainty: new strategies for combining cancer treatments. Cancer Res. 1986; 3886-7. PMID: 3731062

^